navitoclax
abbvie
['melanoma', 'navitoclax']
dr zeynep eroglu presents study of dab/tram +/- navitoclax in braf mutated #melanoma. interesting biological rationale. good use of etctn mechanism to explore combo. some unique stats (not designed to directly compare cohorts) given small n. #asco23 1/ 
Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.